This inventor holds 1 USPTO granted patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jinjin Jiang: Innovator in Cancer Treatment
Introduction
Jinjin Jiang is a notable inventor based in Shandong, China. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the creation of antibodies that can be used for diagnosing and treating various types of cancers.
Latest Patents
Jinjin Jiang holds a patent for an "Antibody against claudin 18A2 and use thereof." This patent includes an anti-CLDN18.2 antibody or an antigen-binding fragment thereof, along with a derivative comprising said antibody or antigen-binding fragment. The pharmaceutical composition and related uses of this antibody are aimed at treating, diagnosing, and detecting cancers. He has 1 patent to his name.
Career Highlights
Jinjin Jiang is associated with Qilu Pharmaceutical Co., Ltd., where he continues to advance his research in the pharmaceutical industry. His work has the potential to impact cancer therapies significantly, providing new avenues for treatment.
Collaborations
Jinjin Jiang collaborates with talented individuals in his field, including Yingying Yang and Gao Li. These partnerships enhance the research and development efforts within his team.
Conclusion
Jinjin Jiang's innovative work in developing antibodies for cancer treatment showcases his dedication to improving healthcare outcomes. His contributions are paving the way for advancements in cancer diagnosis and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile